Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Xilio Therapeutics (XLO)
NASDAQ:XLO
RESEARCH TOOLSreports
Holding XLO?
Track your performance easily
XLO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.49 - $2.94
Previous Close$1.02
Volume91.41K
Average Volume (3M)304.18K
Market Cap
$37.65M
Enterprise Value$12.59M
Total Cash (Recent Filing)$34.00M
Total Debt (Recent Filing)$8.94M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Aug 06, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.57
Shares Outstanding36,912,373
10 Day Avg. Volume860,750
30 Day Avg. Volume304,182
Standard Deviation0.23
R-Squared0.00006
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.30
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xilio Therapeutics News
PremiumCompany Announcements
Xilio Therapeutics Reports Q3 2024 Progress and Financials
PremiumCompany Announcements
Xilio Therapeutics Advances Cancer Drug and Financial Outlook
PremiumCompany Announcements
Xilio Therapeutics Enhances Board with Two New DirectorsOwnership Overview
70.70% Insiders
3.01% Mutual Funds
21.29% Other Institutional Investors
5.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
XLO FAQ
What was Xilio Therapeutics’s price range in the past 12 months?
Xilio Therapeutics lowest stock price was $0.49 and its highest was $2.94 in the past 12 months.
What is Xilio Therapeutics’s market cap?
Currently, no data Available
When is Xilio Therapeutics’s upcoming earnings report date?
Xilio Therapeutics’s upcoming earnings report date is Aug 06, 2024 which is 106 days ago.
How were Xilio Therapeutics’s earnings last quarter?
Xilio Therapeutics released its earnings results on May 14, 2024. The company reported -$0.62 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.51.
Is Xilio Therapeutics overvalued?
According to Wall Street analysts Xilio Therapeutics’s price is currently Overvalued.
Does Xilio Therapeutics pay dividends?
Xilio Therapeutics does not currently pay dividends.
What is Xilio Therapeutics’s EPS estimate?
Xilio Therapeutics’s EPS estimate is -$0.23.
How many shares outstanding does Xilio Therapeutics have?
Xilio Therapeutics has 36,912,373 shares outstanding.
What happened to Xilio Therapeutics’s price movement after its last earnings report?
Xilio Therapeutics reported an EPS of -$0.62 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went down -2.679%.
Which hedge fund is a major shareholder of Xilio Therapeutics?
Among the largest hedge funds holding Xilio Therapeutics’s share is Deerfield Management Company, LP. It holds Xilio Therapeutics’s shares valued at N/A.
---
Xilio Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 3.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.50%
12-Months-Change
Fundamentals
Return on Equity
-128.37%
Trailing 12-Months
Asset Growth
-25.91%
Trailing 12-Months
Company Description
Xilio Therapeutics
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
---
XLO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering XLO
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-42.89%
reiterated a buy rating 12 months ago
Copying Michael Schmidt's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -42.89% per trade.
---